• Citius Oncology announced nationwide deployment of LYMPHIR's broadened commercial organization and expanding market adoption on July 21, 2026.
  • This commercial progress, building on fiscal Q2 2026 results that highlighted $1.7 million in quarterly LYMPHIR net revenue, fueled a multi-day rally.
  • Market participants appear to be taking profits today as broader healthcare names also experience downward pressure.